Ga direct naar de inhoud
Ga direct naar de site navigatie
Ga direct naar zoeken
Maryam Kavousi, born in Shiraz, Iran, in 1975. Ph.D. from Erasmus University Medical Center. Post-doctoral Research Fellow at Erasmus University Medical Center, Rotterdam, the Netherlands.
L’Oréal-UNESCO For Women in Science Fellow (1 September - 30 November 2015)
1. Does the risk age remains similar regardless of the cardiovascular outcome?
2. What is the distribution of risk age and the lifetime cardiovascular risk among women?
3. How does the age gap correspond with lifetime risk prediction among women?
4. How does the age gap correspond with future cardiovascular events among women?
Prevention of cardiovascular disease (CVD) among women remains suboptimal. A substantial group of women have a low risk for developing CVD in short-term but are nevertheless at high risk for developing CVD in their lifetime. There value of the two new concepts of risk age and lifetime cardiovascular risk among women has not been investigated in detail. In this project, I aim to understand how the two concepts of risk age and lifetime CVD risk are related. Meaningful interpretation of these two concepts will allow for their use as effective measures for risk communication between physicians and individuals in primary prevention settings.
1) Kavousi M, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA. 2014;311:1416-1423.
2) Kavousi M, et al. Evaluation of newer risk markers for coronary heart disease risk prediction. Annals of Internal Medicine. 2012;156:438-444.
3) Kavousi M, et al. Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nature Genetics. 2011;43:940-947.
Ga terug naar de bovenkant van deze pagina
Ga terug naar de inhoud
Ga terug naar de site navigatie
Ga terug naar zoeken